Therapy of respiratory syncytial virus infection.
DeVincenzo
J P
JP
Department of Pediatrics, University of Tennessee, Memphis and LeBonheur Children's Medical Center 38103, USA. jdevincenzo@utmem.edu
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D018849:Controlled Clinical Trials as Topic; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D008297:Male; D011379:Prognosis; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000276:immunology* / Q000401:mortality; D012254:Ribavirin / Q000627:therapeutic use*; D018570:Risk Assessment; D015996:Survival Rate; D019562:Viral Load
D000998:Antiviral Agents; D012254:Ribavirin